This website uses cookies to enhance the user experience.
ER

Erik Rosen1964

Shareholdings
12
3
Norway Business roles
18

Roles

Management

NameRoleTotal operating incomeTotal equityShares
A
ANANDA AS
Managing Director/CEO
10,000
1,129,483
92 %
directly
S
SNØTINDENE AS
Managing Director/CEO
-
1,130,569
50 %
directly
A
AFFIN AS
Managing Director/CEO
-
-1,705,639
3.86 %
directly
A
ADVOKATFIRMAET NOVA DA
Managing Director/CEO
30,695,361
6,290,696
-

Boards

NameRoleTotal operating incomeTotal equityShares
A
ANANDA AS
Chairman
10,000
1,129,483
92 %
directly
S
SNØTINDENE AS
Alternate Member
-
1,130,569
50 %
directly
P
PROSA SECURITY AS
Chairman
2,940,509
290,231
21.17 %
directly
C
CHANGETECH AS
Chairman
5,490,619
-3,560,139
9.65 %
indirectly
P
POLYPURE AS
Board Member
27,108,496
18,952,860
6.31 %
directly 3.19 %
indirectly 3.12 %
B
BEAUTIFUL MINDS AS
Alternate Member
213,112
-18,195
-
A
AMICOAT AS
Board Member
7,009,939
63,759,267
-
C
CHIP NANOIMAGING AS
Board Member
456,592
10,142,501
-
Board Member
878,572
33,285,508
-
P
PEPTIDE PATENTS AS
Chairman
900,336
697,496
-
R
ROBERT SANNES AS
Alternate Member
-
31,824
-
A
ADVOKATFIRMAET NOVA DA
Participant with Pro Rata Liability (Shared Liability)
30,695,361
6,290,696
-
Board Member
-
448,105,909
-
N
NORSK ELEKTRO OPTIKK AS
Chairman
135,830,621
106,051,919
-
Last update: Jun 26, 2025

Shares owned by Erik Rosen

NameShare classTotal operating incomeTotal equityShare
A
ANANDA AS
Ordinære aksjer
10,000
1,129,483
92 %
directly
S
SNØTINDENE AS
Ordinære aksjer
0
1,130,569
50 %
directly
P
PROSA SECURITY AS
Ordinære aksjer
2,940,509
290,231
21.17 %
directly
C
CHANGETECH AS
5,490,619
-3,560,139
9.65 %
indirectly
A
AFFIN AS
Ordinære aksjer
0
-1,705,639
3.86 %
directly
B
BILL KILL AS
8,276,418
1,109,406
3.48 %
indirectly
P
POLYPURE AS
Ordinære aksjer
27,108,496
18,952,860
3.19 %
directly 3.19 %
indirectly 3.12 %
B
BITTELILLE AS
Ordinære aksjer
776,879
2,745,564
1 %
directly
S
SENSE BIOPHARMA AS
0
-2,726,672
0.58 %
indirectly
C
COMLIGHT AS
NO0010562317
2,114,572
4,048,000
0.31 %
directly < 0.01 %
L
LYTIX BIOPHARMA AS
NO0010405780
3,991,213
51,319,307
0.06 %
directly < 0.01 %
A
AMICOAT AS
NO0010799679
7,009,939
63,759,267
0.04 %
directly < 0.01 %
A
ADVOKATGUIDEN AS
Ordinære aksjer
2,474,208
-5,150,865
0.02 %
directly < 0.01 %
P
PHARMA HOLDINGS AS
NO0010797350
120,000
8,158,078
< 0.01 %
directly
P
PHARMASUM THERAPEUTICS AS
Ordinære aksjer
989,892
-25,575
< 0.01 %
directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025